Business Information
The group's principal activity is to operate as a venture capital investment company, which invests in private development or start-up companies. The group has made initial investments exclusively in tiny technology, defined by it as nanotechnology, microsystems and microelectromechanical systems. The group performs follow-on investments in the rest of its venture capital portfolio and the group now has 13 investments in tiny technologies. The group operates as an internally managed investment company whereby the officers and employees, under the general supervision of the board of directors, conduct its operations.
|
|
Name |
Title
|
Email
|
| Charles Harris | Chmn., MD, CEO | N/A | | Douglas Jamison | Pres., MD, CFO, COO | N/A | | Sandra Forman | General Counsel, Chief Compliance Officer, Dir. - Human Resources | N/A | | Alexei Andreev | Exec. VP, MD | N/A | | Daniel Wolfe | Principal Since, Sr. Associate, VP | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 3,029 | (11,773) | | 2005 | 15,750 | 6,716 | | 2004 | 638 | (2,066)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
